Intrinsic Value of S&P & Nasdaq Contact Us

Novo Integrated Sciences, Inc. NVOS OTC

Other OTC • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
27/100
0/5 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Stock Statistics — NVOS

Novo Integrated Sciences, Inc. (NVOS) has a market capitalization of $65.11K and trades at $0.00. The 52-week range is 0.0001-0.06.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0, Earnings Per Share (EPS) of $-0.89, annual revenue of $13.29M.

The stock has a beta of 1.10, operates in the Healthcare sector.

Trading Data
Current Price$0.00
52-Week Range0.0001-0.06
Volume1.51K
Avg Volume (30D)3.41K
Market Cap$65.11K
Beta (1Y)1.10
Company
IPO Date2021-02-23
Employees115
CEORobert Mattacchione
CountryUS
ExchangeOther OTC
CurrencyUSD
ISINUS67011T3005
CUSIP67011T201
Income (Latest Year)
Revenue$13.29M
Gross Profit$5.74M
EBITDA$-10.08M
Operating Income$-10.08M
Net Income$-16.13M
EPS$-0.89
EPS Diluted$-0.89
Shares Outstanding$18.03M
Balance Sheet (Latest Year)
Total Assets$32.14M
Current Assets$5.41M
Cash & ST Investments$844.58K
Total Liabilities$17.53M
Total Debt$4.71M
Net Debt$3.87M
Total Equity$14.61M
Debt / Equity0.32
Valuation Ratios
P/E Ratio-0
P/S Ratio0
P/B Ratio0
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message